BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34551595)

  • 1. Development and Validation of Models to Predict Pathological Outcomes of Radical Prostatectomy in Regional and National Cohorts.
    Ötleş E; Denton BT; Qu B; Murali A; Merdan S; Auffenberg GB; Hiller SC; Lane BR; George AK; Singh K
    J Urol; 2022 Feb; 207(2):358-366. PubMed ID: 34551595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing racial disparities in prostate cancer pathology prediction models: external validation and comparison of four models of pathological outcome prediction before radical prostatectomy in the multiethnic SEARCH cohort.
    Mottaghi M; Gu L; Deivasigamani S; Adams ES; Parrish J; Amling CL; Aronson WJ; Kane CJ; Terris MK; Guerrios-Rivera L; Cooperberg MR; Klaassen Z; Freedland SJ; Polascik TJ
    Prostate Cancer Prostatic Dis; 2024 Apr; ():. PubMed ID: 38605270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals.
    Bandini M; Marchioni M; Preisser F; Nazzani S; Tian Z; Fossati N; Gandaglia G; Shariat SF; Montorsi F; Saad F; Briganti A; Tilki D; Karakiewicz PI
    Eur Urol Focus; 2019 May; 5(3):449-456. PubMed ID: 29249688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decision curve analysis to compare 3 versions of Partin Tables to predict final pathologic stage.
    Augustin H; Sun M; Isbarn H; Pummer K; Karakiewicz P
    Urol Oncol; 2012; 30(4):396-401. PubMed ID: 20884254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy.
    Abdollah F; Schmitges J; Sun M; Thuret R; Djahangirian O; Tian Z; Shariat SF; Briganti A; Perrotte P; Montorsi F; Karakiewicz PI
    Urology; 2011 Dec; 78(6):1363-7. PubMed ID: 22137704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion.
    Oderda M; Diamand R; Albisinni S; Calleris G; Carbone A; Falcone M; Fiard G; Gandaglia G; Marquis A; Marra G; Parola C; Pastore A; Peltier A; Ploussard G; Roumeguère T; Sanchez-Salas R; Simone G; Smelzo S; Witt JH; Gontero P
    BJU Int; 2021 Mar; 127(3):318-325. PubMed ID: 32869940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool.
    Gandaglia G; Barletta F; Robesti D; Scuderi S; Rajwa P; Gomez Rivas J; Ibanez L; Soeterik TFW; Bianchi L; Afferi L; Kesch C; Darr C; Guo H; Zhuang J; Zattoni F; Fendler W; Marra G; Stabile A; Amparore D; Huebner NA; Giesen A; Joniau S; Schiavina R; Brunocilla E; Mattei A; Dal Moro F; Sierra JM; Porpiglia F; Picchio M; van den Bergh R; Shariat SF; Montorsi F; Briganti A
    Eur Urol Oncol; 2023 Dec; 6(6):543-552. PubMed ID: 37270378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First North American validation and head-to-head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy.
    Bandini M; Marchioni M; Pompe RS; Tian Z; Gandaglia G; Fossati N; Abdollah F; Graefen M; Montorsi F; Saad F; Shariat SF; Briganti A; Karakiewicz PI
    BJU Int; 2018 Apr; 121(4):592-599. PubMed ID: 29124911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.
    Gandaglia G; Fossati N; Zaffuto E; Bandini M; Dell'Oglio P; Bravi CA; Fallara G; Pellegrino F; Nocera L; Karakiewicz PI; Tian Z; Freschi M; Montironi R; Montorsi F; Briganti A
    Eur Urol; 2017 Oct; 72(4):632-640. PubMed ID: 28412062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.
    Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Fossati N; Stabile A; Beauval JB; Malavaud B; Roumiguié M; Robesti D; Dell'Oglio P; Moschini M; Zamboni S; Rakauskas A; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
    Eur Urol; 2019 Mar; 75(3):506-514. PubMed ID: 30342844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer Patients.
    Chierigo F; Borghesi M; Würnschimmel C; Flammia RS; Sorce G; Hoeh B; Hohenhorst L; Tian Z; Saad F; Tilki D; Gallucci M; Briganti A; Montorsi F; Chun FKH; Shariat SF; Mantica G; Suardi N; Terrone C; Karakiewicz PI
    Clin Genitourin Cancer; 2022 Oct; 20(5):e380-e389. PubMed ID: 35618597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection.
    Gandaglia G; Martini A; Ploussard G; Fossati N; Stabile A; De Visschere P; Borgmann H; Heidegger I; Steinkohl F; Kretschmer A; Marra G; Mathieu R; Surcel C; Tilki D; Tsaur I; Valerio M; Van den Bergh R; Ost P; Gontero P; Montorsi F; Briganti A;
    Eur Urol; 2020 Aug; 78(2):138-142. PubMed ID: 32268944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External Validation of a Multiparametric Magnetic Resonance Imaging-based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy.
    Diamand R; Ploussard G; Roumiguié M; Oderda M; Benamran D; Fiard G; Quackels T; Assenmacher G; Simone G; Van Damme J; Malavaud B; Iselin C; Descotes JL; Roche JB; Peltier A; Roumeguère T; Albisinni S
    Eur Urol; 2021 Feb; 79(2):180-185. PubMed ID: 33023770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-Based External Validation of the Updated 2012 Partin Tables in Contemporary North American Prostate Cancer Patients.
    Leyh-Bannurah SR; Gazdovich S; Budäus L; Zaffuto E; Dell'Oglio P; Briganti A; Abdollah F; Montorsi F; Schiffmann J; Menon M; Shariat SF; Fisch M; Chun F; Graefen M; Karakiewicz PI
    Prostate; 2017 Jan; 77(1):105-113. PubMed ID: 27683103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
    Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
    Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.
    Walz J; Bladou F; Rousseau B; Laroche J; Salem N; Gravis G; Briganti A; Chun FK; Karakiewicz PI; Fournier G
    Urology; 2012 Mar; 79(3):546-51. PubMed ID: 22386393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transperineal template saturation and conventional biopsy for stage prediction in prostate cancer.
    Lehner F; Crippa A; Sigg S; Eberli D; Mortezavi A
    BJU Int; 2023 Dec; 132(6):696-704. PubMed ID: 37704215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do prostate cancer nomograms give accurate information when applied to European patients?
    Turo R; Forster JA; West RM; Prescott S; Paul AB; Cross WR
    Scand J Urol; 2015 Feb; 49(1):16-24. PubMed ID: 24882277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of nomograms predicting lymph node invasion in patients undergoing radical prostatectomy for prostate cancer.
    Nason GJ; O'Connor EM; MacMahon D; Moss B; Considine SW; Cahill A; O'Rourke C; O'Brien FM
    Ir J Med Sci; 2018 Feb; 187(1):33-37. PubMed ID: 28478609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Questioning the Status Quo: Should Gleason Grade Group 1 Prostate Cancer be Considered a "Negative Core" in Pre-Radical Prostatectomy Risk Nomograms? An International Multicenter Analysis.
    Leong JY; Herrera-Caceres JO; Goldberg H; Tham E; Teplitsky S; Gomella LG; Trabulsi EJ; Lallas CD; Fleshner NE; Tilki D; Chandrasekar T
    Urology; 2020 Mar; 137():102-107. PubMed ID: 31705947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.